Skip to content

Clinical trials

Phase 1/2 Prostatic Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 1/2 Country / region: United States Clear all

257 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20014
20025
20034
20047
200511
200615
20075
20087
200910
201010
20117
201211
201310
20142
20158
20168
20177
201812
201913
202012
202110
202210
202312
202414
202516
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed114
Terminated53
Recruiting49
Active, not recruiting21
Unknown status9
Withdrawn6
Not yet recruiting3
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)14
Memorial Sloan Kettering Cancer Center12
AstraZeneca10
M.D. Anderson Cancer Center7
Millennium Pharmaceuticals, Inc.5
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins5
The Methodist Hospital Research Institute5
Rahul Aggarwal4
Weill Medical College of Cornell University4
NYU Langone Health3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms257
Breast Neoplasms28
Ovarian Neoplasms22
Neoplasm Metastasis19
Carcinoma, Non-Small-Cell Lung18
Pancreatic Neoplasms18
Neoplasms16
Colorectal Neoplasms12
Urinary Bladder Neoplasms12
Endometrial Neoplasms11

Trials

Showing 1 to 25 of 257. Each trial links to its page on Pharma Observatory.

157 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.